Related Experiment Video
Updated: Jun 15, 2025

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
Fu's subcutaneous needling approach versus electroacupuncture for knee osteoarthritis: protocol for comparative
Linan Liu1,2, Jian Sun3, Hu Li1,4
1Shandong Provincial Third Hospital, Shandong University, Jinan, Shangdong, China.
Introduction:
With the aging of the population, knee osteoarthritis (KOA) is a common chronic osteoarthritic disorder among middle-aged and elderly people. Fu's subcutaneous needling (FSN) and electroacupuncture (EA) are both effective means of treating KOA. FSN, with characterized by simple operation, quick effect, safety and green,is a modern acupuncture that integrates modern medicine with traditional acupuncture theory. Our team has demonstrated through clinical trials that FSN can effectively relieve pain and improve walking ability in patients with KOA. However, studies on the difference in clinical efficacy of FSN in treating KOA still lack clinical validation with large samples. The purpose of this study was to provide high-level clinical evidence for the clinical management of KOA by comparing the multicenter differences between FSN and EA in the treatment of this disease.
Methods And Analysis:
This study is a prospective, multicenter, randomized controlled trial to compare the efficacy and safety of FSN with EA in the treatment of KOA. This study intends to recruit 300 patients with osteoarthritis of the knee in 6 tertiary hospitals in China, including Shandong Provincial Third Hospital, Shandong University, etc. The group was randomly divided into FSN group and EA group according to 1: 1 ratio. The intervention time is 30 min, and the treatment was carried out three times a week for 4 weeks, and the long-term follow-up was carried out one month after the treatment. The primary outcome index was the response rate of knee symptom relief, and the secondary outcome indexes were the numerical assessment of knee pain (NRS), WOMAC osteoarthritis index, quality of life evaluation (SF-12), 6-min walk test and safety evaluation.
Clinical Trial Registration:
ClinicalTrials.gov, ChiCTR2400080196.
More Related Videos
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
04:57Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment
Published on: April 26, 2024